These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3929824)

  • 1. Once-daily verapamil--an objective evaluation in stable angina pectoris using treadmill exercise testing.
    Raftery EB
    Br J Clin Pract Suppl; 1985 Jun; 42():17-23. PubMed ID: 3929824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ergometric evaluation of the therapeutic effect of prolonged oral administration of delayed-action verapamil on 20 patients with stable effort angina].
    Martiny W; Bottone W; Matta F; Cerrone G; Minelli M; Angelino PF
    Minerva Cardioangiol; 1978 Dec; 26(12):811-8. PubMed ID: 368679
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the efficacy of verapamil in a slow-release preparation in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M; Antuofermo F; Rizzon P
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6765260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the efficacy of verapamil in slow-release preparations in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6927458
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained-release verapamil in stable angina.
    Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():20-3. PubMed ID: 3151265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dazoxiben compared with verapamil in the treatment of stable angina pectoris evaluated by an exercise test].
    Mogensen F; Rasmussen V; Kjøller E; Knudsen JB; Gormsen J
    Ugeskr Laeger; 1985 Jul; 147(29):2299-302. PubMed ID: 3904110
    [No Abstract]   [Full Text] [Related]  

  • 7. An objective comparison of verapamil and placebo in chronic stable angina.
    Balasubramanian V; Raftery EB
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():51-61. PubMed ID: 6811177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and cycloergometric evaluation of verapamil in the therapeutic of angina pectoris].
    Albuquerque DC; Schlesinger P; Benchimol CB; Albanesi FM; Benchimol AB
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():65-70. PubMed ID: 329810
    [No Abstract]   [Full Text] [Related]  

  • 9. [Verapamil in the treatment of angina pectoris. Double-blind study with clinical-cycloergometric correlation].
    Maranhão MF; Lopes M; Toledo MT; Rojas RI; Michelotto PV; Michelotto PV; Lacerda FS; Furlan L; Cunha GP; Oliveira PF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():95-9. PubMed ID: 329814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
    Castro I; Pereira FA; Rodrigues R
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma levels of verapamil and its major metabolites during long-term oral treatment, in chronic stable angina. Correlation with the clinical effects of the drug.
    Zanolla L; Padrini R; Piovan D; Olivieri D; Zardini P
    Cardiologia; 1985 May; 30(5):369-73. PubMed ID: 3833348
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina.
    Rodrigues EA; DasGupta P; Hains AD; Raftery EB
    Eur J Clin Pharmacol; 1988; 34(5):531-2. PubMed ID: 3060361
    [No Abstract]   [Full Text] [Related]  

  • 14. Verapamil administered twice daily in stable angina pectoris.
    Tan AT; Quek S
    Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
    Glasser SP; Gana TJ; Pascual LG; Albert KS
    Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil. An anti-anginal agent.
    Moyer RR
    Minn Med; 1972 Nov; 55(11):1043-5. PubMed ID: 4594260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nitrozell retard in the light of effort tolerance tests on cyclo-ergometer in patients with stable angina pectoris].
    Poprawski K; Dylewicz P; Pelowska J; Wierzchowiecki M; Głuszek J
    Kardiol Pol; 1977; 20(6):471-8. PubMed ID: 415169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Verapamil in effort angina: a multi-centre study].
    Vincenzi M; Braito E; Cappelletti F; Caponnetto S; De Ponti C; Distante R; Masoni A; Palmieri M; Ricciardelli B; Uslenghi E; Zanini S
    G Ital Cardiol; 1982; 12(9):660-5. PubMed ID: 6820344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release and instant-release verapamil in treatment of angina pectoris.
    Jespersen CM; Klitgaard NA; Nielsen H; Hansen JF
    Eur J Clin Pharmacol; 1989; 36(6):625-7. PubMed ID: 2776821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.